EUCTR2015-001344-11-FR进行中（未招募）1 期
Multinational, multicenter, prospective, long-term safety and efficacy follow-up study after Autologous Cultivated Limbal Stem Cells Transplantation (ACLSCT) for restoration of corneal epithelium in patients with limbal stem cell deficiency due to ocular burns (HOLOCORE-FU) - HOLOCORE F
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 75
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •All patients (adults and pediatrics) who completed the HOLOCORE
- •core study and who consent to roll over to the present extension
- •study at the end of the HOLOCORE follow-up.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 5
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 59
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 11
排除标准
- •No specific exclusion criterion is considered for this study, except for
- •patients dropping out from the HOLOCORE study or withdrawing
研究者
相似试验
进行中（未招募）
1 期
A clinical study to follow up the implantation of Holoclar on the cornea of patients with ocular burnsEUCTR2015-001344-11-NLChiesi Farmaceutici S.p.A.70
进行中（未招募）
1 期
A clinical study to follow up the implantation of Holoclar on the cornea of patients with ocular burnsEUCTR2015-001344-11-ITCHIESI FARMACEUTICI S.P.A.70
进行中（未招募）
1 期
A clinical study to follow up the implantation of Holoclar on the cornea of patients with ocular burnsCorneal lesions with associated moderate to severe limbal stem celldeficiency due to ocular burnsMedDRA version: 20.0Level: LLTClassification code 10011012Term: Corneal epithelium opacitySystem Organ Class: 100000004853EUCTR2015-001344-11-ESChiesi Farmaceutici S.p.A.70
进行中（未招募）
1 期
A clinical study to follow up the implantation of Holoclar on the cornea of patients with ocular burnsEUCTR2015-001344-11-DEHolostem Terapie Avanzate s.r.l.70
进行中（未招募）
1 期
A clinical study to follow up the implantation of Holoclar on the cornea of patients with ocular burnsEUCTR2015-001344-11-BEChiesi Farmaceutici S.p.A.70